# Progress Note 03 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Julius Caesar (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC001-SYN
- Date: 2026-09-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucius Fairbanks-Okonkwo, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient, with rapid antigen tests for COVID-19 and influenza

## Chief complaint

Sore throat, blocked nose, cough, and a low fever for three days; asking what he can take for the cold. **S**

## History of present illness

Julius Caesar is a 54-year-old man with focal epilepsy from a chronic left temporal cortical infarct, on levetiracetam 500 mg twice daily for three weeks, and with hypertension and hyperlipidemia on lisinopril, atorvastatin, and aspirin, who came in the same day with three days of sore throat, a blocked and runny nose, a cough with a little clear phlegm, and a temperature up to 37.9 C at home. Several of his staff have had colds. He has slept badly for two nights because of the cough and a run of evening events. He has had no spell, no warning feelings, and no headache beyond a mild frontal ache with the congestion, and he has taken every dose of levetiracetam. He has no breathlessness, chest pain, or ear pain. He asks whether he can take a decongestant cold remedy and ibuprofen, which he used before. He has no new weakness, numbness, speech, or vision change. **S**

| Element | Detail |
|---|---|
| Onset | Three days ago |
| Symptoms | Sore throat, nasal congestion and discharge, cough with clear phlegm, temperature to 37.9 C |
| Context | Colds among his staff; two nights of poor sleep |
| Seizures | None; no missed levetiracetam doses |
| Pertinent negatives | No breathlessness, chest pain, ear pain, or new neurological symptom |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Low fever and tiredness; no rigors |
| Ears, nose, mouth, and throat | Positive | Sore throat, blocked and runny nose; no ear pain |
| Respiratory | Positive | Cough with clear phlegm; no breathlessness or wheeze |
| Cardiovascular | Negative | No chest pain or palpitations |
| Neurological | Negative | No spell, aura, weakness, numbness, speech or vision change; mild frontal ache with congestion |
| Psychiatric | Negative | A little irritable from poor sleep; mood otherwise steady |

6 systems reviewed. **S**

## Current medications

- Lisinopril 10 mg oral tablet, one tablet by mouth daily **S**
- Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtime **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for fever or sore throat (no more than 3 g a day) **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/86 mmHg; pulse 84 bpm; respirations 16/min; temperature 37.8 °C; oxygen saturation 97% on room air; weight 75.4 kg; BMI 22.8 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Tired but well; temperature 37.8 C; oxygen saturation 97 percent |
| Ears, nose, and throat | Nasal mucosa swollen with clear discharge; pharynx red without exudate; tonsils not enlarged; ear drums normal |
| Neck | Small tender anterior cervical nodes |
| Respiratory | Clear to auscultation; no wheeze or crackles |
| Cardiovascular | Regular rhythm; blood pressure 136/86 mmHg |
| Neurological | Alert and oriented; no focal deficit |
| Point-of-care tests | Rapid antigen tests for COVID-19 and influenza A and B negative |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute viral upper respiratory infection** (J06.9). A viral cold with low fever. Negative rapid tests; no signs of streptococcal pharyngitis (cough, no exudate), sinusitis, or pneumonia, so no antibiotic. The cough began with the cold, so it is not the dry cough that lisinopril can cause; if a dry cough outlasts the cold, that will be reconsidered. **S**
   - Acetaminophen 500 to 1000 mg every 6 hours as needed, no more than 3 g a day.
   - Avoid decongestants (pseudoephedrine and phenylephrine), which raise blood pressure, and ibuprofen and other NSAIDs, which raise blood pressure and add bleeding risk with aspirin.
   - Avoid sedating antihistamines, which add to the drowsiness levetiracetam can cause; use saline nasal rinses, honey, and fluids instead.
   - Return or call for breathlessness, fever above 38.5 C for more than three days, or symptoms lasting beyond ten days.
2. **Focal epilepsy on levetiracetam** (G40.209). No seizure; every dose taken. Fever and lost sleep both lower the seizure threshold. **S**
   - Continue levetiracetam 500 mg twice daily; do not skip doses while unwell.
   - Cancel evening events this week and sleep at least seven hours.
   - Seizure action plan unchanged; staff know what to do.
3. **Hypertension on lisinopril** (I10). 136/86 mmHg with a fever; above target, to be reassessed when well. **S**
   - Continue lisinopril 10 mg; review at next week's visit.

## Medication changes

- Started: Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for fever or sore throat (no more than 3 g a day) **S**

## Guideline basis

- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018), American Academy of Neurology and American Epilepsy Society (Neurology)
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021), American Heart Association and American Stroke Association (Stroke)
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Hypertension)

## Follow-up

- Four-week chronic-care visit next week as scheduled; sooner for the warning signs above. **S**
- Next scheduled visit 2026-09-15: four-week review of levetiracetam, blood pressure, the second rhythm monitor, mood, and cognition. **S**
